[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5483/BMBRep.2016.49.9.030

Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression

Peng, Yaojin (Department of Human Anatomy, Medical College of Hunan Normal University)
Zhong, Yan (Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University)
Li, Gao (Department of Thoracic Surgery, Hainan General Hospital)

Publication Information

BMB Reports / v.49, no.9, 2016 , pp. 502-507 More about this Journal

Abstract

To examine the effect of TBMS1on breast cancer metastasis, and investigate the potential mechanism by which Tubeimoside-1 (TBMS1) inhibits the CXCR4 expression in breast cancer cells. The expression of CXCR4 in breast cancer cell lines was determined by immunoblotting and real-time PCR. The effect of TBMS1 on NF-κB binding activity was evaluated by EMSA assay and ChIP analysis. Cell proliferation and invasion were analyzed by MTT assay and transwell invasion assay, respectively. The effect of TBMS1 on breast cancer metastasis was further evaluated in a metastasis model of nude mice. TBMS1 suppressed the expression of CXCR4 through inhibition of NF-κB binding activity. TBMS1 inhibited CXCL12-induced invasion in breast cancer cells, while ectopic expression of CXCR4 abolished the inhibitive activity of TBMS1. TBMS1 suppressed breast cancer metastasis in the metastatic model of nude mice. TBMS1 suppressed the CXCR4-mediated metastasis of breast cancer by inhibiting NF-κB binding activity.

Keywords

Breast cancer; CXCR4; Metastasis; Tubeimoside-1;

Citations & Related Records

Reference

1	Raman D, Baugher PJ, Thu YM and Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256, 137-165 DOI
2	Geiger TR and Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796, 293-308
3	Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25, 345-356 DOI
4	Franco R, Pirozzi G, Scala S et al (2012) CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood. Eur J Cardiothorac Surg 41, 368-375 DOI
5	Zeelenberg IS, Ruuls-Van Stalle L and Roos E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63, 3833-3839
6	Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS and McCauley LK (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62, 1832-1837
7	Mori T, Doi R, Koizumi M et al (2004) CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3, 29-37
8	Richert MM, Vaidya KS, Mills CN et al (2009) Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. Oncol Rep 21, 761-767
9	Gu Y, Korbel C, Scheuer C, Nenicu A, Menger MD and Laschke MW (2015) Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model. Oncotarget 7, 5258-5272
10	Yadav VR, Sung B, Prasad S et al (2010) Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. J Mol Med (Berl) 88, 1243-1253 DOI
11	Yu TX, Ma RD and Yu LJ (2001) Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects. Acta Pharmacol Sin 22, 463-468
12	Bian Q, Liu P, Gu J and Song B (2015) Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/beta-catenin signaling pathway. Int J Clin Exp Pathol 8, 12517-12524
13	Lin Y, Xie G, Xia J et al (2016) TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53/MDM2-dependent mechanism, a quantitative proteomics study. Biochim Biophys Acta 1864, 204-210 DOI
14	Jia G, Wang Q, Wang R et al (2015) Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway. Onco Targets Ther 8, 303-311
15	Chen WJ, Yu C, Yang Z et al (2012) Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca(2)(+) and caspase-dependent signaling pathways. Int J Oncol 40, 535-543
16	Hao W, Wang S and Zhou Z (2015) Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway. Int J Clin Exp Pathol 8, 12075-12083
17	Xu C, Zhao H, Chen H and Yao Q (2015) CXCR4 in breast cancer: oncogenic role and therapeutic targeting. Drug Des Devel Ther 9, 4953-4964
18	Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D and Jain RK (2011) CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res 17, 2074-2080 DOI
19	Kukreja P, Abdel-Mageed AB, Mondal D, Liu K and Agrawal KC (2005) Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 65, 9891-9898 DOI
20	Nevo I, Sagi-Assif O, Meshel T et al (2004) The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells. Immunol Lett 92, 163-169 DOI
21	Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ and Krek W (2003) Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307-311 DOI
22	Richard CL and Blay J (2007) Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner. Int J Oncol 30, 1215-1222
23	Huang P, Yu C, Liu XQ, Ding YB, Wang YX and He JL (2011) Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway. Int J Mol Med 28, 579-587
24	Dalerba P and Clarke MF (2007) Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell 1, 241-242 DOI

Reference

17	Seulah Lee. (2017) Bioorganic & Medicinal Chemistry Letters Chemical constituents from the rare mushroom Calvatia nipponica inhibit the promotion of angiogenesis in HUVECs / 27 (17) , 4122
10	Seulah Lee. (2017) Molecules Anti-Inflammatory Phenolic Metabolites from the Edible Fungus Phellinus baumii in LPS-Stimulated RAW264.7 Cells / 22 (10) , 1583
	Seulah Lee. (2017) Journal of Functional Foods Anti-inflammatory activity of the sclerotia of edible fungus, Poria cocos Wolf and their active lanostane triterpenoids / 32 , 27
3	(2016) Oncology Letters Farnesyl transferase inhibitor FTI-277 inhibits breast cell invasion and migration by blocking H-Ras activation / 12 (3) , 2222
8	(2018) BMB Reports Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes / 51 (8) , 394
1	(2018) International Journal of Molecular Sciences Chemical Characterization of a Renoprotective Metabolite from Termite-Associated Streptomyces sp. RB1 against Cisplatin-Induced Cytotoxicity / 19 (1) , 174
11	(2018) Cell Death & Disease Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function / 9 (11)
11	(2018) Molecules Tirucallane Triterpenoids from the Stems and Stem Bark of Cornus walteri that Control Adipocyte and Osteoblast Differentiations / 23 (11) , 2732
3	(2018) Journal of Cancer Prevention Diallyl Trisulfide Suppresses the Production of Lipopolysaccharide-induced Inflammatory Mediators in BV2 Microglia by Decreasing the NF-κB Pathway Activity Associated With Toll-like Receptor 4 and CXCL12/CXCR4 Pathway Blockade / 23 (3) , 134
11	(2018) Biomedical Chromatography A hybrid method for the determination of tubeimoside I in rat plasma after oral administration by LC-IT-TOF and UPLC-MS/MS / 32 (11) , e4337
8	(2018) Archives of Pharmacal Research Bioactivity evaluations of betulin identified from the bark of Betula platyphylla var. japonica for cancer therapy / 41 (8) , 815
9	(2018) Chemistry & Biodiversity in LPS-Stimulated RAW264.7 Macrophages / 15 (9) , e1800203
1	(2018) Journal of Enzyme Inhibition and Medicinal Chemistry on adipocyte differentiation and mature adipocyte metabolism / 33 (1) , 1167